Stock Scorecard
Stock Summary for Medtronic Plc (MDT)
Total Score
13 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MDT
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MDT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MDT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for MDT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Financial Details for MDT
Company Overview |
|
|---|---|
| Company Name | Medtronic Plc |
| Country | USA |
| Description | Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US. |
| Sector Name | LIFE SCIENCES |
| Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Most Recent Quarter | 10/31/2022 |
| Next Earnings Date | 2/21/2023 |
Stock Price History |
|
| Last Day Price | 79.12 |
| Last Day Volume | 4,879,811 |
| Average Daily Volume | 7,183,737 |
| 52-Week High | 112.54 |
| 52-Week Low | 76.60 |
| Last Price to 52 Week Low | 3.29 % |
Valuation Measures |
|
| Trailing PE | 20.44 |
| Industry PE | 91.55 |
| Sector PE | 93.21 |
| 5-Year Average PE | 23.68 |
| Free Cash Flow Ratio | 11.84 |
| Industry Free Cash Flow Ratio | 20.74 |
| Sector Free Cash Flow Ratio | 37.54 |
| Book Value Per Share Most Recent Quarter | 39.00 |
| Price to Book Ratio | 1.99 |
| Industry Price to Book Ratio | 8.58 |
| Sector Price to Book Ratio | 15.42 |
| Price to Sales Ratio Twelve Trailing Months | 3.42 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.02 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.17 |
Share Statistics |
|
| Total Shares Outstanding | 1,329,150,000 |
| Market Capitalization | 105,162,348,000 |
| Institutional Ownership | 83.29 % |
Dividends |
|
| Ex-Dividend Date | 9/22/2022 |
| Last Dividend Amount | 0.68 |
| Current Dividend Amount | 0.68 |
| Dividend Aristocrat? | False |
| Forward Annual Dividend Rate | 2.52 |
| Forward Annual Dividend Yield | 2.08 % |
| Trailing Annual Dividend Rate | 2.62 |
| Trailing Annual Dividend Yield | 3.49 % |
| 5-Year Average Dividend Yield | 0.00 % |
| 5-Year Dividend Payments Count | 21 |
| Dividend Payout Ratio | 46.40 % |
Income Statement |
|
| Quarterly Earnings Growth YOY | -67.00 % |
| Annual Earnings Growth | 39.74 % |
| Reported EPS Past Year | 2.43 |
| Reported EPS Prior Year | 5.62 |
| Net Income Twelve Trailing Months | 5,205,000,000 |
| Net Income Past Year | 5,039,000,000 |
| Net Income Prior Year | 3,606,000,000 |
| Quarterly Revenue Growth YOY | -3.30 % |
| 5-Year Revenue Growth | 1.62 % |
Balance Sheet |
|
| Total Cash Per Share | 6.68 |
| Total Cash Most Recent Quarter | 8,873,000,000 |
| Total Cash Past Year | 10,573,000,000 |
| Total Cash Prior Year | 10,817,000,000 |
| Net Cash Position Most Recent Quarter | -8,608,000,000 |
| Net Cash Position Past Year | -37,816,000,000 |
| Long Term Debt Past Year | 48,389,000,000 |
| Long Term Debt Prior Year | 52,976,000,000 |
| Total Debt Most Recent Quarter | 17,481,000,000 |
| Equity to Debt Ratio Past Year | 0.52 |
| Equity to Debt Ratio Most Recent Quarter | 0.75 |
| Current Ratio Most Recent Quarter | 1.58 |
| Total Stockholder Equity Past Year | 52,551,000,000 |
| Total Stockholder Equity Prior Year | 51,428,000,000 |
| Total Stockholder Equity Most Recent Quarter | 52,672,000,000 |
Options |
|
| Put/Call Ratio | 1.45 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| MACD | -1.53 |
| MACD Signal | -1.09 |
| 20-Day Bollinger Lower Band | 99.73 |
| 20-Day Bollinger Middle Band | 103.43 |
| 20-Day Bollinger Upper Band | 107.12 |
| Beta | 0.78 |
| RSI | 39.52 |
| 50-Day SMA | 94.84 |
| 200-Day SMA | 101.10 |
System |
|
| Modified | 11/26/2022 6:30:09 PM |